| Inventor | Institute |
|---|---|
| June L. Biedler, Barbara A. Spengler, Lawrence Helson | Memorial Sloan-Kettering Cancer Center (MSK) |
| SKU: | 161936 |
|---|---|
| Product description: | SK-N-MC was originally described as a neuroblastoma cell line. It is now widely regarded as having originated from an Askin’s tumour (Ewing family of tumours). |
| Gender: | Female |
| Products or characteristics of interest: | Karyotype: The cell line is a pseudodiploid human female (XX), with chromosome counts in the diploid range and a modal chromosome number of 46. Normal chromosomes N3 and N10 are absent, and many (N1, N2, N4, N15, N16, N17, N21, and N22) are monosomic. Normal chromosome N8 is most often tetrasomic. The remainder of normal chromosomes were usually paired. Numerous marker chromosomes are present including: 1p+, der(3)t(2;3)(q24;q27), del(4)(p12), 11q+, del(2)(q23), ampl.(17)(p12), ampl.(16)(q13), del(15)(q13q22), 21p+, iso(3q), del(22)(q11q13). Marker chromosomes M2 and M3 appear to us to be identical to two markers (M4 and M3, respectively) described by R.C. Seeger, et al.for this cell line. Isoenzymes: AK-1, 1 ES-D, 2 G6PD, B GLO-I, 1-2 Me-2, 2 PGM1, 1 PGM3, 1-2 |
| Cat. #: | 161936 |
|---|---|
| Cancer types: | Neuroblastoma |
| Tissue: | Brain |
| Gender: | Female |
| Morphology: | Epithelial |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Neuroblastoma |
| Primary citation: | Biedler et al. Cancer research. 1973. 33(11):2643-2652. PMID: 4748425. |
| Shipping conditions: | Dry Ice |
|---|---|
| Growth medium: | 1:1 mixture of ATCC-formulated Eagle’s Minimum Essential Medium, Catalog No. 30-2003, and F12 Medium then supplemented with fetal bovine serum to a final concentration of 10%. |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 in air |
| Storage medium: | Complete growth medium supplemented with 5% DMSO |
| Biosafety level: | 1 |
| References: |
Helson et al. 1975. Cancer Research. 35(9):2594-2599. PMID:167965. Biedler et al. 1978. Cancer research. 38:3751-3757. PMID: 29704. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.